PureTech Health plc (OTCMKTS:PTCHF) Short Interest Up 1,723.1% in February

PureTech Health plc (OTCMKTS:PTCHF) saw a significant increase in short interest in February. As of February 15th, there was short interest totalling 47,400 shares, an increase of 1,723.1% from the January 31st total of 2,600 shares. Based on an average trading volume of 1,400 shares, the short-interest ratio is presently 33.9 days.

PureTech Health Stock Performance

Shares of PTCHF opened at $1.74 on Friday. PureTech Health has a twelve month low of $1.66 and a twelve month high of $3.00. The company has a 50 day moving average of $1.80 and a two-hundred day moving average of $1.95.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.